Norm

ISO 20916:2019 en

In vitro diagnostic medical devices - Clinical performance studies using specimens from human subjects - Good study practice

163,97 178,73 Incl BTW

Over deze norm

Status Definitief
Aantal pagina's 56
Commissie In vitro diagnostica
Gepubliceerd op 01-06-2019
Taal Engels
ISO 20916 defines good study practice for the planning, design, conduct, recording and reporting of clinical performance studies carried out to assess the clinical performance and safety of in vitro diagnostic (IVD) medical devices for regulatory purposes.The document is not intended to describe whether the technical specifications of the IVD medical device in question are adequately addressed by the clinical performance study. This document identifies the principles that underpin clinical performance studies and specifies general requirements intended to - ensure the conduct of the clinical performance study will lead to reliable and robust study results, - define the responsibilities of the sponsor and principal investigator, - assist sponsors, clinical research organization, investigators, ethics committees, regulatory authorities and other bodies involved in the conformity assessment of IVD medical devices, and - protect the rights, safety, dignity and well-being of the subjects providing specimens for use in clinical performance studies. Analytical performance studies are out of the scope of this document.Clinical performance studies that are performed for reasons other than pre- and post-market regulatory purposes, such as for re-imbursement purposes, are out of the scope of this document.This document does not include safety information for laboratory workers or other personnel collecting the study specimens.

Details

ICS-code 11.100.10
Engelse titel In vitro diagnostic medical devices - Clinical performance studies using specimens from human subjects - Good study practice

Winkelwagen

Subtotaal:

Ga naar winkelwagen